Metabolic actions of neuropeptide Y and their relevance to obesity.
Wilding
J P
JP
Division of Endocrinology and Metabolism, Royal Postgraduate Medical School, Hammersmith Hospital, London, U.K.
D000818:Animals; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D004734:Energy Metabolism / Q000187:drug effects; D005247:Feeding Behavior; D006706:Homeostasis; D006801:Humans; D007031:Hypothalamus / Q000502:physiology*; D008071:Lipoprotein Lipase / Q000378:metabolism; D051379:Mice; D008820:Mice, Obese; D008954:Models, Biological; D009478:Neuropeptide Y / Q000494:pharmacology / Q000502:physiology*; D009765:Obesity / Q000503:physiopathology*; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D011924:Rats, Zucker; D017476:Receptors, Neuropeptide Y / Q000502:physiology
D004040:Dietary Carbohydrates; D004041:Dietary Fats; D009478:Neuropeptide Y; D017476:Receptors, Neuropeptide Y; D008071:Lipoprotein Lipase